Aristada Approved for Schizophrenia
Charles Makhoul
Aristada (aripiprazole lauroxil) extended release injection has been approved by the U.S. Food and Drug Administration to treat the disabling brain disorder schizophrenia, the agency said Tuesday in a news release.
To continue reading this article please click on the link below:
https://www.nlm.nih.gov/medlineplus/news/fullstory_155010.html